Parameter | Control group | CRVO group | P value* |
---|---|---|---|
GCC (μm) | |||
Baseline | 114.2 ± 15.6 | 104.2 ± 25.4 | 0.022 |
First year | 112.7 ± 15.6 | 98.3 ± 22.1 | |
Second year | 112.9 ± 12.6 | 95.8 ± 24.2 | |
Third year | 113.1 ± 11.2 | 90.6 ± 20.8 | |
P value† | 0.695 | < 0.001 | |
INL (μm) | |||
Baseline | 40.7 ± 3.7 | 41.6 ± 8.3 | 0.466 |
First year | 40.7 ± 3.6 | 39.4 ± 8.4 | |
Second year | 40.4 ± 3.6 | 38.3 ± 9.5 | |
Third year | 40.0 ± 3.7 | 37.2 ± 9.1 | |
P value† | 0.084 | < 0.001 | |
OPL (μm) | |||
Baseline | 33.3 ± 4.7 | 35.5 ± 7.8 | 0.080 |
First year | 32.1 ± 4.2 | 33.6 ± 7.7 | |
Second year | 32.8 ± 4.5 | 32.5 ± 7.7 | |
Third year | 33.2 ± 4.8 | 32.3 ± 7.1 | |
P value† | 0.783 | < 0.001 | |
ONL (μm) | |||
Baseline | 69.3 ± 9.7 | 69.9 ± 15.9 | 0.817 |
First year | 70.3 ± 9.8 | 65.6 ± 13.9 | |
Second year | 69.7 ± 10.2 | 62.6 ± 12.5 | |
Third year | 68.8 ± 10.8 | 62.0 ± 14.2 | |
P value† | 0.295 | < 0.001 | |
PRL (μm) | |||
Baseline | 66.8 ± 2.5 | 66.5 ± 1.9 | 0.566 |
First year | 66.6 ± 2.4 | 66.7 ± 2.5 | |
Second year | 65.9 ± 5.4 | 66.7 ± 2.8 | |
Third year | 66.6 ± 2.3 | 66.6 ± 3.1 | |
P value† | 0.318 | 0.863 | |
RPE (μm) | |||
Baseline | 15.4 ± 1.9 | 15.3 ± 4.2 | 0.814 |
First year | 15.5 ± 2.0 | 15.5 ± 3.5 | |
Second year | 15.5 ± 2.4 | 16.3 ± 5.5 | |
Third year | 15.5 ± 1.9 | 16.1 ± 6.3 | |
P value† | 0.991 | 0.092 |